Search Results
Megan J. Baier
Partner
Megan represents technology and life sciences clients in corporate transactional matters.
Mark B. Baudler
Partner
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
Steven V. Bernard
Partner
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Richard C. Blake
Partner
Richard has a comprehensive corporate law background, with extensive experience in public offerings.
Jonathan Chan
Partner
Jonathan represents technology-driven clients in corporate and transactional matters.
Weiheng Chen
Partner
Weiheng leads Wilson Sonsini's Greater China practice and he focuses on capital markets, M&A, and private equity transactions.
Michael E. Coke
Partner
Michael represents technology-driven clients in corporate, securities, and related transactional matters.
Colin G. Conklin
Partner
Colin G. Conklin is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on public and private offerings of securities for issuers and underwriters, SEC reporting, corporate governance and general corporate counseling of emerging growth technology and life sciences companies.
Michael J. Danaher
Partner
Mike has more than 20 years of experience representing technology and life sciences companies in corporate matters.
Brian Dillavou
Partner
Brian Dillavou is a corporate partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where he represents start-ups and emerging growth companies from incorporation and early-stage financings through strategic exits such as initial public offerings and mergers and acquisitions. His experience includes advising start-up and early-stage businesses on corporate legal issues, venture capital and other financings, stock options and other compensation matters, mergers and acquisitions, and capital markets transactions, including initial public offerings. He also represents institutional investors and financial institutions in venture capital financings, mergers and acquisitions, and capital markets transactions, including initial public offerings and other equity and debt financings. Brian has particular experience working with clients in the technology, fintech, and life sciences sectors.
Salil Gandhi
Partner
Salil Gandhi is a partner in the New York office of Wilson Sonsini Goodrich & Rosati and a co-leader of the firm’s emerging companies practice. Salil focuses on corporate and securities law and specializes in the representation of emerging growth companies throughout their lifecycles, particularly in the life sciences and technology sectors. He also counsels venture capital funds and other private equity funds on structuring and executing investment transactions ranging from angel to control investments, as well as portfolio dispositions.
Stephen R. Heifetz
Partner
Stephen advises clients on laws and policies at the intersection of international business and national security. He previously served in the U.S. government on the Committee on Foreign Investment in the U.S.
Andrew D. Hoffman
Partner
Andrew’s practice focuses on corporate and securities work for companies at all stages of growth, as well as for financial institutions, venture capital firms, and other investors.
Robert T. Ishii
Partner
Rob represents technology and life sciences clients in M&A and other transformative deals.
Kathy H. Ku
Partner
Katherine H. Ku is a corporate and securities partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati. She represents both public and private companies and private equity funds in a variety of corporate transactions, including mergers and acquisitions, equity and debt financings, and joint ventures. Kathy also advises clients on corporate governance and securities compliance matters. In addition, she has experience representing special committees of boards of directors in connection with buy-out matters.